Back
Cyclacel Pharmaceuticals Stock Price Chart
Sell
47
CYCC
Cyclacel Pharmaceuticals
Last Price:
2.29
Seasonality Move:
-13.89%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and CYCC is experiencing slight selling pressure.
Cyclacel Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.42 | Sell |
| 20-day SMA: | 2.16 | Buy |
| 50-day SMA: | 2.15 | Buy |
| 200-day SMA: | 4.25 | Sell |
| 8-day EMA: | 2.37 | Sell |
| 20-day EMA: | 2.24 | Buy |
| 50-day EMA: | 2.26 | Buy |
| 200-day EMA: | 4.67 | Sell |
Cyclacel Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 51.56 | Buy |
| Chaikin Money Flow: | -9645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.7 - 2.46) | Buy |
| Bollinger Bands (100): | (1.97 - 2.69) | Sell |
Cyclacel Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cyclacel Pharmaceuticals Stock
Is Cyclacel Pharmaceuticals Stock a Buy?
- Cyclacel Pharmaceuticals share price is 2.29 while CYCC 8-day simple moving average is 2.42, which is a Sell signal.
- The stock price of CYCC is 2.29 while Cyclacel Pharmaceuticals 20-day SMA is 2.16, which makes it a Buy.
- Cyclacel Pharmaceuticals 50-day simple moving average is 2.15 while CYCC share price is 2.29, making it a Buy technically.
- CYCC stock price is 2.29 and Cyclacel Pharmaceuticals 200-day simple moving average is 4.25, creating a Sell signal.
CYCC Technical Analysis vs Fundamental Analysis
Sell
47
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Is Cyclacel Pharmaceuticals a Buy or a Sell?
-
Cyclacel Pharmaceuticals stock is rated a Sell
The current Cyclacel Pharmaceuticals [CYCC] share price is $2.29. The Score for CYCC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Cyclacel Pharmaceuticals Stock Info
Market Cap:
3.02M
Price in USD:
2.29
Share Volume:
32.64K
Cyclacel Pharmaceuticals 52-Week Range
52-Week High:
13.20
52-Week Low:
1.30
Sell
47
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Cyclacel Pharmaceuticals Share Price Forecast
-
What is the Cyclacel Pharmaceuticals stock price today?
The Cyclacel Pharmaceuticals stock price is 2.29 USD today. -
Will CYCC stock go up or go down?
Cyclacel Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Cyclacel Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cyclacel Pharmaceuticals is overvalued.
Is Cyclacel Pharmaceuticals Stock a Buy?
- Cyclacel Pharmaceuticals share price is 2.29 while CYCC 8-day exponential moving average is 2.37, which is a Sell signal.
- The stock price of CYCC is 2.29 while Cyclacel Pharmaceuticals 20-day EMA is 2.24, which makes it a Buy.
- Cyclacel Pharmaceuticals 50-day exponential moving average is 2.26 while CYCC share price is 2.29, making it a Buy technically.
- CYCC stock price is 2.29 and Cyclacel Pharmaceuticals 200-day simple moving average is 4.67, creating a Sell signal.
Fundamental Analysis of Cyclacel Pharmaceuticals
Is Cyclacel Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $4.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $21.67 per share, and an increase next year of $1.36 per share.
Technical Analysis of Cyclacel Pharmaceuticals
Should I short Cyclacel Pharmaceuticals stock?
- CYCC Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Cyclacel Pharmaceuticals is a Buy
- Cyclacel Pharmaceuticals Relative Strength Index (RSI) is 51.56, which suggest Cyclacel Pharmaceuticals is overbought
- The Bollinger Bands (25) for Cyclacel Pharmaceuticals is (1.7 - 2.46), which suggest Cyclacel Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Cyclacel Pharmaceuticals is (1.97 - 2.69), which suggest Cyclacel Pharmaceuticals is a Sell
* Cyclacel Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.